Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 13 September 2006. doi:10.1136/jmg.2006.044859
Journal of Medical Genetics 2007;44:38-43
Copyright © 2007 by the BMJ Publishing Group Ltd.

ORIGINAL ARTICLE

Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations

M Fanin, A C Nascimbeni, C Angelini

Department of Neurosciences, University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy

Correspondence to:
Dr M Fanin
Venetian Institute of Molecular Medicine, via Giuseppe Orus 2, 35129 Padova, Italy; marina.fanin{at}unipd.it

Background: The diagnosis of calpainopathy is obtained by identifying calpain-3 protein deficiency or CAPN3 gene mutations. However, in many patients with limb girdle muscular dystrophy type 2A (LGMD2A), the calpain-3 protein quantity is normal because loss-of-function mutations cause its enzymatic inactivation. The identification of such patients is difficult unless a functional test suggests pursuing a search for mutations.

Materials and methods: A functional in vitro assay, which was able to test calpain-3 autolytic function, was used to screen a large series of muscle biopsy specimens from patients with unclassified LGMD/hyperCKaemia who have previously shown normal calpain-3 protein quantity.

Results: Of 148 muscle biopsy specimens tested,17 samples (11%) had lost normal autolytic function. CAPN3 gene mutations were identified in 15 of 17 patients (88%), who account for about 20% of the total patients with LGMD2A diagnosed in our series.

Conclusions: The loss of calpain-3 autolytic activity is highly predictive of primary calpainopathy, and the use of this test as part of calpainopathy diagnosis would improve the rate of disease detection markedly. This study provides the first evidence of the pathogenetic effect of specific CAPN3 gene mutations on the corresponding protein function in LGMD2A muscle and offers new insights into the structural–functional relationship of the gene and protein regions that are crucial for the autolytic activity of calpain-3.

Abbreviations: LGMD, limb girdle muscular dystrophy; LGMD2A, limb girdle muscular dystrophy type 2A; SSCP, single-strand conformational polymorphism; TTBS, Tris-buffered saline with Tween-20


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Groen, E. J., Charlton, R., Barresi, R., Anderson, L. V., Eagle, M., Hudson, J., Koref, M. S., Straub, V., Bushby, K. M. D. (2007). Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 130: 3237-3249 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs